CS236488B2 - Method of new suphimines production - Google Patents
Method of new suphimines production Download PDFInfo
- Publication number
- CS236488B2 CS236488B2 CS825591A CS559182A CS236488B2 CS 236488 B2 CS236488 B2 CS 236488B2 CS 825591 A CS825591 A CS 825591A CS 559182 A CS559182 A CS 559182A CS 236488 B2 CS236488 B2 CS 236488B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- butoxy
- title compound
- prepared
- theory
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19813129444 DE3129444A1 (de) | 1981-07-25 | 1981-07-25 | "sulfoximine, deren herstellung und diese verbindungen enthaltende arzneimittel" |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS236488B2 true CS236488B2 (en) | 1985-05-15 |
Family
ID=6137766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS825591A CS236488B2 (en) | 1981-07-25 | 1982-07-22 | Method of new suphimines production |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JPS5824559A (enExample) |
| KR (1) | KR840000491A (enExample) |
| AR (1) | AR230745A1 (enExample) |
| AU (1) | AU556082B2 (enExample) |
| CA (1) | CA1175430A (enExample) |
| CS (1) | CS236488B2 (enExample) |
| DD (1) | DD202871A5 (enExample) |
| DE (2) | DE3129444A1 (enExample) |
| DK (1) | DK329582A (enExample) |
| ES (4) | ES8305333A1 (enExample) |
| FI (1) | FI822550A7 (enExample) |
| GR (1) | GR76181B (enExample) |
| HU (1) | HU188188B (enExample) |
| NO (1) | NO822255L (enExample) |
| PL (1) | PL137725B1 (enExample) |
| PT (1) | PT75297A (enExample) |
| SU (1) | SU1158041A3 (enExample) |
| YU (1) | YU158182A (enExample) |
| ZA (1) | ZA825273B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7863283B2 (en) * | 2008-01-17 | 2011-01-04 | Bayer Schering Pharma Ag | Sulphoximine-substituted quinazoline derivatives as immuno-modulators, their preparation and use as medicaments |
-
1981
- 1981-07-25 DE DE19813129444 patent/DE3129444A1/de not_active Withdrawn
-
1982
- 1982-06-30 NO NO822255A patent/NO822255L/no unknown
- 1982-07-16 SU SU823463928A patent/SU1158041A3/ru active
- 1982-07-20 FI FI822550A patent/FI822550A7/fi not_active Application Discontinuation
- 1982-07-20 YU YU01581/82A patent/YU158182A/xx unknown
- 1982-07-21 DD DD82241832A patent/DD202871A5/de unknown
- 1982-07-21 PL PL1982237600A patent/PL137725B1/pl unknown
- 1982-07-21 AR AR290035A patent/AR230745A1/es active
- 1982-07-22 DK DK329582A patent/DK329582A/da not_active Application Discontinuation
- 1982-07-22 HU HU822373A patent/HU188188B/hu unknown
- 1982-07-22 CS CS825591A patent/CS236488B2/cs unknown
- 1982-07-22 PT PT75297A patent/PT75297A/pt unknown
- 1982-07-23 JP JP57128814A patent/JPS5824559A/ja active Pending
- 1982-07-23 GR GR68840A patent/GR76181B/el unknown
- 1982-07-23 AU AU86378/82A patent/AU556082B2/en not_active Ceased
- 1982-07-23 ZA ZA825273A patent/ZA825273B/xx unknown
- 1982-07-23 ES ES514275A patent/ES8305333A1/es not_active Expired
- 1982-07-23 CA CA000407915A patent/CA1175430A/en not_active Expired
- 1982-07-24 KR KR1019820003316A patent/KR840000491A/ko not_active Ceased
- 1982-12-18 DE DE19823246980 patent/DE3246980A1/de not_active Withdrawn
-
1983
- 1983-01-07 ES ES518826A patent/ES8400410A1/es not_active Expired
- 1983-01-07 ES ES518827A patent/ES518827A0/es active Granted
- 1983-01-07 ES ES518828A patent/ES518828A0/es active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| ES8400412A1 (es) | 1983-10-16 |
| ZA825273B (en) | 1984-03-28 |
| SU1158041A3 (ru) | 1985-05-23 |
| ES8400411A1 (es) | 1983-10-16 |
| AU556082B2 (en) | 1986-10-23 |
| ES518826A0 (es) | 1983-10-16 |
| AU8637882A (en) | 1983-04-14 |
| PL137725B1 (en) | 1986-07-31 |
| PL237600A1 (en) | 1983-03-28 |
| ES514275A0 (es) | 1983-04-01 |
| FI822550A0 (fi) | 1982-07-20 |
| HU188188B (en) | 1986-03-28 |
| KR840000491A (ko) | 1984-02-22 |
| ES8305333A1 (es) | 1983-04-01 |
| FI822550L (fi) | 1983-01-26 |
| ES8400410A1 (es) | 1983-10-16 |
| JPS5824559A (ja) | 1983-02-14 |
| DD202871A5 (de) | 1983-10-05 |
| ES518827A0 (es) | 1983-10-16 |
| FI822550A7 (fi) | 1983-01-26 |
| YU158182A (en) | 1984-08-31 |
| AR230745A1 (es) | 1984-06-29 |
| ES518828A0 (es) | 1983-10-16 |
| PT75297A (fr) | 1982-08-01 |
| DE3246980A1 (de) | 1984-06-20 |
| NO822255L (no) | 1983-01-26 |
| GR76181B (enExample) | 1984-08-03 |
| DE3129444A1 (de) | 1983-02-10 |
| CA1175430A (en) | 1984-10-02 |
| DK329582A (da) | 1983-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20040039198A1 (en) | Compounds | |
| JP2695852B2 (ja) | 薬剤組成物 | |
| NO136595B (enExample) | ||
| KR100232324B1 (ko) | 허혈성 질환을 예방 및 치료하기 위한 트로폴론 유도체 및 그의 약학 조성물 | |
| EP3154941B1 (en) | Small molecule lfa-1 inhibitors | |
| CS236488B2 (en) | Method of new suphimines production | |
| SU1107759A3 (ru) | Способ получени производных индолинона | |
| US4889866A (en) | Arylsulfonyl dihydropyridine derivatives | |
| FI79704C (fi) | Foerfarande foer framstaellning av benzoxazin-2-oner. | |
| US4696937A (en) | Thiosulfonate derivatives for inhibiting malformation or destruction of red blood corpuscules | |
| CN103781791A (zh) | 具有噁唑并[4,5-c]吡啶环的羧酸衍生物 | |
| EP0071150B1 (de) | Sulfimine, deren Salze und deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel | |
| NO142403B (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive isokinoliner | |
| US3133933A (en) | Certain | |
| CN103781790A (zh) | 具有噁唑并[5,4-b]吡啶环的羧酸衍生物 | |
| EP0310648B1 (en) | Condensation products of 2,2,4-trimethyl-1,2-dihydro-quinoline and oxo compounds and derivatives thereof | |
| US3356732A (en) | 2-[p-(phenylsulfonyl) phenyl]-1, 3-indanedione and its tautomer | |
| DE3143327A1 (de) | "neue indolinone, ihre herstellung und ihre verwendung als arzneimittel" | |
| RU2671983C9 (ru) | Антикоагулянтное средство непрямого действия на основе диуманкала | |
| RU2030408C1 (ru) | Производные оксазола | |
| Hendess | 1, 4-Benzoxazines. Conversion to a benzoxazole and an indolo [3, 2-b][1, 4] benzoxazine | |
| DE3142904A1 (de) | Arzneimittel zur vermeidung von tumormetasierung | |
| HK1157325A (en) | 5-(4-methanesulfonyl-phenyl)-thiazole derivatives for the treatment of acute and chronic inflammatory diseases | |
| SI8010849A8 (sl) | Postopek za pridobivanje 3-(metiltio, metilsulfinil ali metilsulfonil)-4-kinolonov | |
| CS235176B1 (cs) | Substituované 4-fenoxy-3-methyl-llí-pýtaždlo(3j4-b)chinoliny a způsoby jejich přípravy |